… be a role for L-T4 treatment in decreasing cancer risk in patients … L-thyroxine-treated patients
with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: …

… Thyroid carcinomas are fairly uncommon and include disease types that range from indolent
localised papillary carcinomas to … a consensus about treatment of thyroid carcinoma have …

… Our aim was to investigate the effect of L-thyroxine (L-T4) on the frequency of PTC … untreated
(nZ20 055) or treated with L-T4 (nZ7859). L-T4-treated patients with respect to untreated …

… earlier therapy after L-T4 withdrawal, underwent (131)I treatment while euthyroid on L-T4, …
Post-therapy WBS was performed one week later. Three patients received only rhTSH (131)…

… Withdrawal of 1-thyroxine replacement treatment in athyreotic patients for four weeks before
test doses of 131I, led to falls of serum T4 and T3 concentration and a progressive rise of …

… ment with LT4 following the total thyroidectomy and radioiodine ablative therapy were included
in the … thyroid carcinoma treated with chronic TSH-suppressive therapy. (J. Endocrinol. …

… Our results also begin to address the question of the optimal dose of LT~ for treating patients
with differentiated thyroid cancer. The data confirm previous observations that there is a …

… thyroid cancers are differentiated papillary or follicular types. The treatment of differentiated
thyroid carcinoma (… radioactive iodine ablation therapy, followed by L-thyroxine therapy. The …

… thyroid carcinoma are not at increased risk of developing low bone mass nor have a
higher prevalence of vertebral fracture at least when treated with relatively low doses of l-thyroxine. …

… molecular tumor marker in papillary thyroid carcinoma, and the … of vascular invasion in
follicular thyroid carcinoma (7, 8). … thyroxine administration is a cornerstone of the further care of …